X
FDA okays Viatris’ insulin drug as first ‘interchangeable’ biosimilar
https://pharmaphorum.com/news/fda-okays-mylan-insulin-drug-as-first-interchangeable-biosimilar/
Lantus
Sanofi beats expectations, driven by rare diseases and vaccines
But sales of key insulin fall amid biosimilar competition.